Home R&D Page 5

R&D

A partnership for ultra-rare disease APECED/APS-1

Looking for extractables and leachables

Negative opinion for anamorelin hydrochloride

Results from EMBRACA Phase 3 trial in breast cancer

Erenumab to prevent migraine: results from phase III STRIBE

New orphan drug for high grade serous epithelial ovarian cancer

Haemophilia A: rurioctocog alfa pegol recommended by CHMP

Positive results of phase 2 trial on nivolumab/ipilimumab Combo in SCLC

Negative topline results of intepirdine phase 3 MINDSET trial in Alzheimer’s...

Alzheimer’s disease: trigriluzole phase 2 trial in collaboration with ADCS

1...456...16Page 5 of 16
© © 2025 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151